Heidi Leister-Tebbe, BSN (she/her/hers)

Clinician/Clinical Lead
Pfizer Inc
Collegeville, Pennsylvania, United States

Heidi Leister-Tebbe is a Senior Director within Pfizer Research & Development at Pfizer Inc (Collegeville, PA). Heidi brings more than 20 years of pharmaceutical experience dedicated to anti-infective development. Since joining Pfizer (formerly Wyeth) in 2004, Heidi has worked in a variety of clinical and medical affairs roles to support various anti-infective research and clinical development programs and brand lifecycle strategies. Heidi currently is a Global Clinical Lead and Clinician, leading strategy and clinical development activities for PAXLOVID and EMBLAVEO in the Infectious Diseases Group. Prior to entering the industry, Heidi worked as a critical care nurse and received her BS of Nursing from the University of Pennsylvania.

Disclosure(s): Pfizer Inc: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 88 - Efficacy of nirmatrelvir-ritonavir in high-risk trial participants with prior SARS-CoV-2 infection or vaccination: a pooled analysis

  Thursday, October 17, 2024
  10:42 AM – 10:54 AM US PT

• 580 - Pharmacokinetics (PK) and Safety of Nirmatrelvir/Ritonavir (NMV/r) in Non-Hospitalized Symptomatic Pediatric Patients Ages 6 Years and Older with COVID-19 who are at Increased Risk of Progression to Severe Disease (EPIC-Peds)

  Saturday, October 19, 2024
  2:45 PM – 2:57 PM US PT